The Oncosearch | Oncotarget

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss Research Paper

Maroun Bou Zerdan, Prashanth Ashok Kumar, Elio Haroun, Nimisha Srivastava, Jeffrey Ross, Abirami Sivapiragasam

Published Feb 25, 2023 · Vol. 14, No. 1 · pp. 178-187

Keywords: breast cancer, metastatic, MTAP loss

The nuclear envelope and metastasis Editorial

Emily Hansen, James M. Holaska

Published Feb 17, 2023 · Vol. 14, No. 1 · pp. 317-320

Keywords: emerin, metastasis, mechanotransduction, breast cancer, nucleoskeleton

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer Editorial

Brian Diskin, Sarah Schwartz, George Miller

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 364-365

Keywords: pancreatic cancer, liver metastasis, immunnotherapy

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? Editorial

Laura Garcia-Gerique, Yulia Nefedova

Published Feb 16, 2023 · Vol. 14, No. 1 · pp. 258-260

Keywords: PAD4, PMN-MDSC, neutrophils, neutrophil migration

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation Addendum

Karam Khaddour, Joshua Dowling, Jiayi Huang, Martha Council, David Chen, Lynn Cornelius, Tanner Johanns, Sonika Dahiya, George Ansstas

Published Feb 8, 2023 · Vol. 14, No. 1 · pp. 126-126

Intraventricular immunovirotherapy; a translational step forward Research Perspective

Joshua D. Bernstock, Sarah Blitz, Kyung-Don Kang, Gregory K. Friedman

Published Dec 30, 2022 · Vol. 14, No. 1 · pp. 40-43

Keywords: oncolytic virotherapy, herpes simplex virus (HSV), G207, intraventricular therapy, leptomeningeal disease

Impact of Covid-19 on the management of patients with metastatic melanoma Research Paper

Michèle Welti, Phil F. Cheng, Joanna Mangana, Mitchell P. Levesque, Reinhard Dummer, Laurence Imhof

Published Dec 14, 2022 · Vol. 13, No. 1 · pp. 1370-1379

Keywords: metastatic melanoma, Covid-19, Sars-CoV-2, immunotherapy, targeted therapy

Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study Addendum

Silvia P. Corona, Fabiola Giudici, Guy Jerusalem, Eva Ciruelos, Carla Strina, Marianna Sirico, Ottavia Bernocchi, Manuela Milani, Martina Dester, Nicoletta Ziglioli, Giuseppina Barbieri, Valeria Cervoni, Filippo Montemurro, Daniele Generali

Published Nov 18, 2022 · Vol. 13, No. 1 · pp. 1307-1307

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation Addendum

Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Alfredo Carrato, Enrique Grande

Published Nov 15, 2022 · Vol. 13, No. 1 · pp. 1245-1245

Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Correction

Balraj Singh, Vanessa N. Sarli, Hannah E. Kinne, Anna Shamsnia, Anthony Lucci

Published Nov 15, 2022 · Vol. 13, No. 1 · pp. 1272-1272

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells Research Paper

Ida Steiro, Esten N. Vandsemb, Samah Elsaadi, Kristine Misund, Anne-Marit Sponaas, Magne Børset, Pegah Abdollahi, Tobias S. Slørdahl

Published Oct 15, 2022 · Vol. 13, No. 1 · pp. 1175-1186

Keywords: matriptase, multiple myeloma, tumor suppressor, migration, Src

Nectin-4 is widely expressed in head and neck squamous cell carcinoma Research Paper

Christine Sanders, Jan-Frederic Lau, Dimo Dietrich, Sebastian Strieth, Peter Brossart, Glen Kristiansen

Published Oct 14, 2022 · Vol. 13, No. 1 · pp. 1166-1173

Keywords: Nectin-4, enfortumab-vedotin, HNSCC, p16

Addendum: A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy Addendum

Matteo Torresetti, Donatella Brancorsini, Francesca Morgese, Valeria Cognigni, Alessandro Scalise, Rossana Berardi, Giovanni Di Benedetto

Published Oct 14, 2022

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report Addendum

Javad Nazarian, Gary E. Mason, Cheng Ying Ho, Eshini Panditharatna, Madhuri Kambhampati, L. Gilbert Vezina, Roger J. Packer, Eugene I. Hwang

Published Oct 11, 2022 · Vol. 14, No. 1 · pp. 449-449

Genomic alterations predictive of poor clinical outcomes in pan-cancer Research Paper

Crystal S. Seldon, Karthik Meiyappan, Hannah Hoffman, Jimmy A. Guo, Neha Goel, William L. Hwang, Paul L. Nguyen, Brandon A. Mahal, Mohammed Alshalalfa

Published Sep 20, 2022 · Vol. 13, No. 1 · pp. 1069-1077

Keywords: genomic alterations, TP53, TCGA, poor prognosis

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation Research Paper

Melanie Demes, Ursula Pession, Jan Jeroch, Falko Schulze, Katrin Eichler, Daniel Martin, Peter Wild, Oliver Waidmann

Published Sep 8, 2022 · Vol. 13, No. 1 · pp. 1034-1042

Keywords: anal cancer, microsatellite instability, immunotherapy, high-throughput nucleotide sequencing, nivolumab

Correction: Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer Correction

Bruna Cândido Guido, Douglas Cardoso Brandão, Ana Luisa Augusto Barbosa, Monique Jacob Xavier Vianna, Lucas Faro, Luciana Machado Ramos, Fabíola Nihi, Márcio Botelho de Castro, Brenno A.D. Neto, José Raimundo Corrêa, Sônia Nair Báo

Published Aug 5, 2022 · Vol. 13, No. 1 · pp. 1068-1068

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Andliena Tahiri, Katarina Puco, Faris Naji, Vessela N. Kristensen, Glenny Cecilie Alfsen, Lorant Farkas, Frode S. Nilsen, Stig Müller, Jan Oldenburg, Jürgen Geisler

Published Jul 8, 2022 · Vol. 13, No. 1 · pp. 970-981

Keywords: kidney cancer, kinase activity, tyrosine kinase inhibitors, renal cell carcinoma, tyrosine kinase

Role of germline variants in the metastasis of breast carcinomas Research Paper

Ángela Santonja, Aurelio A. Moya-García, Nuria Ribelles, Begoña Jiménez-Rodríguez, Bella Pajares, Cristina E. Fernández-De Sousa, Elísabeth Pérez-Ruiz, María del Monte-Millán, Manuel Ruiz-Borrego, Juan de la Haba, Pedro Sánchez-Rovira, Atocha Romero, Anna González-Neira, Ana Lluch, Emilio Alba

Published Jun 27, 2022 · Vol. 13, No. 1 · pp. 843-862

Keywords: breast cancer, germline variants, epistasis, network analysis, seed and soil

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss Research Paper

The nuclear envelope and metastasis Editorial

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer Editorial

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? Editorial

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation Addendum

Intraventricular immunovirotherapy; a translational step forward Research Perspective

Impact of Covid-19 on the management of patients with metastatic melanoma Research Paper

Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study Addendum

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation Addendum

Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Correction

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells Research Paper

Nectin-4 is widely expressed in head and neck squamous cell carcinoma Research Paper

Addendum: A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy Addendum

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report Addendum

Genomic alterations predictive of poor clinical outcomes in pan-cancer Research Paper

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation Research Paper

Correction: Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer Correction

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Role of germline variants in the metastasis of breast carcinomas Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss Research Paper

The nuclear envelope and metastasis Editorial

The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer Editorial

Neutrophil PAD4: how does it function in cancer beyond promoting NETosis? Editorial

Addendum: Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation Addendum

Intraventricular immunovirotherapy; a translational step forward Research Perspective

Impact of Covid-19 on the management of patients with metastatic melanoma Research Paper

Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study Addendum

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation Addendum

Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Correction

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells Research Paper

Nectin-4 is widely expressed in head and neck squamous cell carcinoma Research Paper

Addendum: A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy Addendum

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report Addendum

Genomic alterations predictive of poor clinical outcomes in pan-cancer Research Paper

Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation Research Paper

Correction: Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer Correction

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors Research Paper

Role of germline variants in the metastasis of breast carcinomas Research Paper